Structure
| PDB | Resolution (Å) | PDB name |
|---|---|---|
| 1ZUA | 1.25 | Crystal Structure Of AKR1B10 Complexed With NADP+ And Tolrestat |
| 4GA8 | 1.942 | Human AKR1B10 mutant V301L complexed with NADP+ and sorbinil |
| 4GAB | 1.5971 | Human AKR1B10 mutant V301L complexed with NADP+ and fidarestat |
| 4GQ0 | 2.1 | Crystal structure of AKR1B10 complexed with NADP+ and Caffeic acid phenethyl ester |
| 4GQG | 1.92 | Crystal structure of AKR1B10 complexed with NADP+ |
| 4I5X | 2.1 | Crystal Structure Of AKR1B10 Complexed With NADP+ And Flufenamic acid |
| 4ICC | 1.752 | Crystal structure of human AKR1B10 complexed with NADP+ and JF0064 |
| 4JIH | 2.3 | Crystal Structure Of AKR1B10 Complexed With NADP+ And Epalrestat |
| 4JII | 2.2 | Crystal Structure Of AKR1B10 Complexed With NADP+ And Zopolrestat |
| 4WEV | 1.453 | Crystal structure of human AKR1B10 complexed with NADP+ and sulindac |
| 4XZL | 1.7 | Crystal structure of human AKR1B10 complexed with NADP+ and JF0049 |
| 4XZM | 1.75 | Crystal structure of the methylated wild-type AKR1B10 holoenzyme |
| 4XZN | 1.7 | Crystal structure of the methylated K125R/V301L AKR1B10 Holoenzyme |
| 5LIK | 2.05 | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK181 |
| 5LIU | 1.75 | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor IDD388 |
| 5LIW | 1.75 | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK319 |
| 5LIX | 1.95 | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK184 |
| 5LIY | 2.05 | Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK204 |
| 5M2F | 1.503 | Crystal structure of human AKR1B10 complexed with NADP+ and the synthetic retinoid UVI2008 |
| 5Y7N | 2.5 | Crystal structure of AKR1B10 in complex with NADP+ and Androst-4-ene-3-beta-6-alpha-diol |
